ETFMG Treatments Testing and Advancements ETF’s (GERM) Moving Averages Convergence Divergence (MACD) indicator is 0.46, suggesting ETFMG Treatments Testing and Advancements ETF is a Sell.
ETFMG Treatments Testing and Advancements ETF’s (GERM) 20-Day exponential moving average is 18.30, making it a Buy.
ETFMG Treatments Testing and Advancements ETF’s (GERM) 50-Day exponential moving average is 18.03, making it a Buy.